IS30YX

IS30YX is a radiopharmaceutical diagnostic PET imaging agent currently in the discovery stage, developed by iSeek Biopharma for applications in immuno-oncology. While the specific molecular target for this candidate has not been publicly disclosed, iSeek Biopharma's core technology platform focuses on developing radiopharmaceuticals that target receptors on leukocytes to visualize immune cell trafficking and activity. As a PET imaging agent, IS30YX is intended to provide non-invasive diagnostic insights into the immune microenvironment of tumors, potentially aiding in the selection of patients for immunotherapy or monitoring their response to treatment.